EDTA PROCEEDINGS

 

 

 

 

 

VOLUME 17

 

 

 

 

 

PRAGUE - 1980

 

 

 

 

 

 

 

 

 

 

INTRODUCTION

 

 

 

 

 

Cover [PDF]

 

 

 

 

 

Preface [PDF]

 

 

 

 

 

Contents [PDF]

 

 

 

 

 

Foreword [PDF]

 

 

 

 

 

Part I – STATISTICAL REPORTS

Page

 

 

 

 

Combined Report on Regular Dialysis and Transplantation in Europe, X, 1979   [PDF]

 

 

FP Brunner, H Brynger, C Chantler, RA Doncherwolche, RA Hatway, C Jacobs, P Kramer, N H Selwood, A J Wing

 

 

 

 

 

 

Combined Report on Regular Dialysis and Transplantation of Children in Europe, 1979   [PDF]

87

 

 

RA Doncherwolche, C Chantler, M Broyer, FP Brunner, H Brynger, C Jacobs, P Kramer, NH Selwood, AJ Wing

 

 

       

Part II – SYMPOSIUM ON ACUTE RENAL FAILURE

 

 

 

 

 

 

Phatophysiology and prevention of acute renal failure [PDF]

119

 

 

K Thurau

 

 

       

Can acute renal failure in human be prevented? [PDF]

123

 

 

V E Andreucci, A Dal Canton

 

 

       

On the onset of acute tubular necrosis with a view towards prevention [PDF]

132

 

 

A Chapman

 

 

       

Part III  -  GUEST LECTURE

 

 

 

 

 

 

On the pathogenesis of sexual dysfuncion of the uraemic male [PDF]

139

 

 

S G Massry, D A Goldstein, W R Procci, O A Kletzky

 

 

 

 

 

 

Part IV – HAEMODIALYSIS

 

 

 

 

 

 

Risk factors in chronic haemodialysis [PDF]

149

 

 

P Degoulet, J Reach, F Aime, P Rioux, C Jacobs, M Legrain

 

 

 

 

 

 

Pathophysiology of dialysis related hypoxaemia [PDF]

155

 

 

H Graf, H K Stummvoll, P Haber, J Kovarik

 

 

 

 

 

 

Is there a dissociation erythropoietic proliferation and serum erythropoietin levels in renal failure patients on longterm haemodialysis treatment? [PDF]

162

 

 

A J Walle, W Niedermayer

 

 

 

 

 

 

Visual function can be preserved in insulin-dependent diabetic patients treated by maintenance haemodialysis [PDF]

167

 

 

Y El Shahat, J Rottenbourg, P Bellio, M C Guimont, F Rousselie, C Jacobs

 

 

       

A non-A non-B hepatitis epidemic in an HB antigen-free haemodialysis unit. Demonstration of serological markers of non-A non-B virus [PDF]

173

 

 

N Simon, J P Mery, C Trepo, L Vitvitski, A M Couroucè

 

 

       

Portable system for simultaneus measurements of blood electrolytes [PDF]

179

 

 

J Harrow, J Janata, R L Stephen, W J Kolff

 

 

       

Part   V –HAEMOFILTRATION

 

 

 

 

 

 

Cold carbon haemofiltration apparatus [PDF]

186

 

 

C Giordano, R Esposito, P Bello, E Quarto, M Pluvio

 

 

 

 

 

 

Absence of transcellular fluid shift during haemofiltration [PDF]

192

 

 

G Kimura, A Irie, K Kuroda, S Kojima, M Satani

 

 

 

 

 

 

Response of the vascular system to different modifications of haemofiltration and haemodialysis [PDF]

197

 

 

E Quellhorst, B Schuenemann, U Hildebrand, Z Falda

 

 

 

 

 

 

Differing haemodynamic stability due to differing sympathetic response: comparison of ultrafiltration, haemodialysis and haemofiltration [PDF]

205

 

 

C A Baldamus, W Ernst, W Fassbinder, K M Koch

 

 

 

 

 

 

Part   VI – ALUMINIUM

 

 

 

 

 

 

Aluminium transfer in bicarbonate dialysis using a sorbent regenerative system: an in vitro study [PDF]

213

 

 

B Branger, P Ramperez, N Marigliano, H Mion, S Shaldon, C Mion

 

 

 

 

 

 

Positive aluminium balance in patients on regular peritoneal treatment: an effect of low dialysate pH? [PDF]

219

 

  P Gilli, P De Bastiani, F Fagioli, U Buoncristiani, C Carobi, N Stabellini, R Squerzanti, G Rosati, A Farinelli    
        

Reversible microcytic hypocrhomic anaemia in dialysis patients due to aluminium intoxication [PDF]

226

 

 

A J K Short, R J Winney, J S Robson

 

 

 

 

 

 

Dialysis encephalopathy. Diagnostic and prognostic value of clinical and EEG signs, and aluminium levels in serum and cerebrospinal fluid [PDF]

234
 

 

J P Adehmar, J Laederich, M C Jaudon, J P Masselot, C Buisson, A GAlli, D Kleinknecht    
       

PART VII – TRANSPLANTATION 2

 

 

 

 

 

 

The effect of chronic renal failure in rabbits on plasma lipids and the concentration of cholesterol, calcium and phosphate in the aortic wall [PDF]

240

 

 

E Tvedegaard, O Kamstrup

 

 

 

 

 

 

HDL cholesterol and intravenous fat tolerance in dialysis patients [PDF]

247

 

 

M K Chan, Z Varghese, J W Persaud, R A Baillod, J F Moorhead

 

 

 

 

 

 

The effect of hepain-free dialysis on abnormal lipid metabolism in patients on regular dialysis treatment [PDF]

253

 

 

N Matsui, Y Nakamura, T Shinoda, H Iwamoto, N Yoshiyama, S Nakagawa, J Takeuchi, J Teraoka

 

 

 

 

 

 

Improvement of post-heparin lipolytic activity (PHLA) after haemofiltration, in uraemic patients [PDF]

259

 

 

S di Giulio, B Lacour, M Thevenin, C Basile, T Drueke, N K Man

 

 

 

 

 

 

PART VIII – CONTINUOUS AMBULATORY PERITONEAL DIALYSIS

 

 

 

 

 

 

Continuous ambulatory peritoneal dialysis without wearing a bag: complete freedom of patient and significant reduction of peritonitis [PDF]

266

 

 

G Bazzato, U Coli, S Landini, S Lucatello, A Fracasso, M Moracchiello

 

 

 

 

 

 

The adequacy of six litre daily continuous ambulatory peritoneal dialysis [PDF]

276

 

 

A M W Forbes, V L Reed, H J Goldsmith

 

 

 

 

 

 

Metabolic effects of continuous ambulatory peritoneal dialysis [PDF]

283

 

 

B Lindholm, A Alvestrand, P Furst, S G Karlander, H E Norbeck, M Ahlberg, A Tranaeus, J Bergstrom

 

 

 

 

 

 

Fungal peritonitis in patients undergoing chronic intermittent or continuous ambulatory peritoneal dialysis [PDF]

291

 

 

R Khanna, D G Oreopulos, S Vas, W McCready, N Dombros

 

 

 

 

 

 

PART IX – POSTERS ON DIALYSIS

 

 

 

 

 

 

Arterio-venous fistulas constructed with formalin-fixed human umbilical grafts [PDF]

297

 

  H V Zuhlke, A Anders, R Haring

 

 

 

 

 

 

Manufactured homologous vein graft for creation of arterio-venous fistula [PDF]

303

 

 

Ph Bonnaud, D messier, N-K Man

 

 

 

 

 

 

Impairment of the mental status of patients on regular dialysis treatment [PDF]

306

 

 

P Gilli, P bastiani, G Rosati, O Fiocchi, R Squerzanti, G Tataranni, A Farinelli

 

 

 

 

 

 

The influence of uraemic neurophaty on muscle: EMG, histoenzymatic and ultrastructural correlations [PDF]

312

 

 

G M Savazzi, V Cambi, L Migone, A Marbini, E Govoni, M M Bragaglia, G Juvarra, P P Dall'Aglio

 

 

 

 

 

 

Use of prostacyclin in regular dialysis therapy [PDF]

318

 

 

J H Turney, L C Williams, M R Fewell, V parsons, M J Weston

 

 

 

 

 

 

Effects of prostacyclin suppression in hypogonadism in patients on maintenance haemodialysis [PDF]

323

 

 

L Tharandt, N Graben, R Schafer, G Plewa, K Joachim, R Siegel, G Benker, D Reinwein

 

 

       

Semicontinuous semiambulatory peritoneal dialysis [PDF]

328

 

 

U Buoncristiani, M Cozzari, C Carobi, G Quintaliani, D Barbarossa, N De Paolo

 

 

       

Continuous ambulatory peritoneal dialysis and pulmonary function [PDF]

333

 

 

H Thieler, E Riedel, W Pielesch, R Berzon, V v Paris

 

 

       

High precision adjustment of ultrafiltration and reinjection flow rates during the haemofiltration procedure [PDF]

337

 

 

T Hass, F Khazine, G Dongradi, O Simons, C fraumont, J P Fendler

 

 

       

Urea and nitroen metabolism in patients treated with haemofiltration [PDF]

341

 

 

A Saito, H Asada, K Maeda, K Ohta

 

 

       

Cascade filtration for separating plasma proteins of different: molecular weights [PDF]

347

 

 

H G Sieberth, H Kierdorf, W M Glockner

 

 

       

Membrane plasma separation: procedural reccomendation [PDF]

353

 

 

K Sprenger, H E Franz

 

 

       

Handy type haemofiltration-plasma exchange apparatus [PDF]

357

 

 

O Otsubo, T Horluchi, S Seo, T Dohi, F Fukui, T Inou

 

 

       

Serum levels of PTH, Mg, Ca, inorganic phosphate and alkaline phosphatases in uraemic patients on differentiated Mg dialysis [PDF]

362

 

 

M Gonella, L Moriconi, G betti, F Bonaguidi, G Buzzigoli, V Bartolini, G Mariani

 

 

       

Drug treatment of hypertriglyceridaemia in chronic uraemic patients: preliminary report on D.L-carnitine and Thiadenol [PDF]

367

 

 

G Giorcelli, G Vacha, G P Icardi

 

 

       

PART X – GUEST LECTURE

 

 

 

 

 

Immunodeficiency in chronic renal insufficiency [PDF]

375

 

 

J Traeger, J L Touraine, J Navarro, J Freyria, P Contreras

 

 

       
PART XI – SYMPOSIUM ON CORTICOSTEROID DOSAGE IN RENAL TRANSPLANTATION    
     

Corticosteroid therapy for renal transplantation [PDF]

385

 

 

Mary G McGeown

 

 

 

 

 

Are there non steroid-dependent rejection episodes? [PDF]

391

 

 

J crosnier, H Kreis, J M Descamps, R Mansouri

 

 

     

Steroids and rejection treatment in the Gothenburg transplant programme [PDF]

395

 

 

H Brynger, L E Gelin

 

 

     

PART XII – TRANSPLANTATION 1

 

 

 

 

 

Renal allograft finction and cytomegaly

[PDF]

407

 

 

Jirka J, M Horcickova, I Reneltova, P Rossmann, J Seeman, V Hola, V Kocandrle

 

 

 

 

 

Sonographic features of ATN and of acute rejection in renal allografts [PDF]

413

 

 

C Cruz, H Hricak, W R Eyler, N W Levin, M Uniewski

 

 

 

 

 

Diagnostic evaluation of the in situ inflammatory response of renal allograft rejection[PDF]

418

 

 

C Leithner, H Sinzinger, K Silberbauer, A Wolf, H K Stummvoll, W Pinggera

 

 

     

Enhanced prostacyclin synthesis in acute human kidney transplant rejection [PDF]

424

 

 

C Leithner, H Sinzinger, K Silberbauer, A Wolf, H K Stummvoll, W Pinggera

 

 

     

A controlled trial evaluating intensive plasma exchange in renal transplant recipints[PDF]

429

 

 

C J Cardella, D M C Sutton, A Katz, P R Uldall, M Harding, P N Corey, G T Cook, G A Deveber

 

 

     

Less aggressive rejection therapy and low-dose corticosteroids leading to satisfactory cadaveric kidney graft survival amd low morbidity rate [PDF]

435

 

 

J P van Hooff, A van Es, M I Koolen, M W Kalff, P H van den Broek, J de Graeff

 

 

     
PART XIII – TRANSPLANTATION 2    

 

 

 

Machine preservation of 450 cadaver kidneys [PDF]

440

 

 

F K Merkel, K B Espe, S C Jensik

 

 

 

 

 

Non-heratbeating donors, is it worthwhile [PDF]

445

 

 

J A van der Vliet, M J H Slooff, G Dootstra, R A F Krom, B G Rijkmans

 

 

     

Results of kidney transplantation in relation to HLA-A, B, DR matching and quality of donor organ [PDF]

450

 

 

V Lenhard, K Dreikorn, L Rohl

 

 

     

Modification of kidney graft survival in dog and man by pre-operative transfusion to the donor organ [PDF]

457

 

 

J Jeekel, C J Van der Linden, P A Vegt, W A Buurman, F Harder, G Persijn

 

 

     

Outcome of repeated renal regrafting [PDF]

462

 

 

B Frisk, J Ahlmen, H Brynger, L Sandberg, L-E Gelin

 

 

     

Plasma 1,25(OH)2 D3 and iPTH in transplanted adults with persisting hypophasphataemia [PDF]

467

 

 

A Ulmann, N Chkoff, M Garabedian, B Lacour, J M Descamps, H Kreis, J Crosnier, J L Funck-Brentano

 

 

       
PART XIV – NEPHROLOGY 5    
     

Early diagnosis of cytomegalovirus infection in renal transplantation [PDF]

473

 

 

C Feletti, M Musiani, V Bonomini

 

 

     

Prognostic significance of B and T cell antibodies in kidney transplantation [PDF]

478

 

 

V Lenhard, W rettwitz, K dreikorn, L Rohl

 

 

     

T-active rosette forming cells as a better index of kidney transplantation recipients'immune reactivity [PDF]

483

 

 

G Civati, B Brando, M L Broggi, P Cosci, L Minetti

 

 

     

Serological study of patients receiving prospective blood transfusion before kidney tranplantation [PDF]

486

 

 

T Nebout, C Bracq, P Mannioni, G Fruchaud, C Abbou

 

 

     

Reversal of rejection and subsidence of immunoglobulinuria by intensive plasmapheresis[PDF]

491

 

 

L Burrows, H Schanzer, M Haimov, K jhaveri, V deutsch, E Ambinder, K Kwun

 

 

     

Alternate day steroids and blood pressure control after renal transplantation [PDF]

496

 

 

M I McHugh, H Tanboga, R Wilkinson

 

 

     

Incidence of cancer in renal transplant recipients [PDF]

496

 

 

A G R Shell, J May, J F Mahoney, J S Horvath, J R Johnson, D J Tiller, J H Stewart

 

 

     

Risks and benefits of bilaterial nephrectomy: an analysis of 134 cases [PDF]

507

 

 

L C Williams, J H Turney, M Bewick, C J Rudge, S A Snowden, M weston, V Parsons

 

 

     

The timing of immunosuppressive therapy and suppression of the immune response [PDF]

512

 

 

M S Knapp, N P Byrom, R Pownall

 

 

     
PART XV – SYMPOSIUM ON PSYCHOLOGICAL AND SOCIO-ECONOMIC ASPECTS OF DIALYSIS AND TRANSPLANTATION    
     

Introductory remarks

[PDF]

519

 

 

H E Wardener

 

 

     

Medical staffs' attitudes and patients' rehabilitation

[PDF]

520

 

 

A Kaplan De-Nour

 

 

     

The "uncooperative" patient with ESRD, causes and treatment [PDF]

523

 

 

N B Levy

 

 

     
PART XVI – RENAL OSTEODYSTROPHY    
     

The evolution of renal osteodystrophy in patients undergoing continuous ambulatory peritoneal dialysis (CAPD) [PDF]

533

 

 

V Calderaro, D G Oreaopulos, H E Meema, R Ogilvie, H Husdan, R Khanna, C Quinton, T Murray, D Carmichael

 

 

     

Comparison of 1,25(OH)2D3 and 24,25(OH)2D3 in the long-term treatment of renal osteodystrophy [PDF]

543

 

 

N Muirhead, G R D Catto, N Edward, R A Fraser, J L H O'Riordan, S E Papapoulos, S Adami

 

 

     

24,25 dihydroxycalciferol: assay in non-anephric patients on chronic haemodialysis and assessment of its possible pathophysiological role in renal osteodystrophy

[PDF]

548

 

 

G Lambrey, T M Nguyen, A Fournier, J L Sebert, J Kassouf, J F de Fremont, P Marie, P Meunier, C Caillens, J Gueris, M Garabedian, S Balsan

 

 

     

Direct feed-back regulation of PTH-secretion by 1,25-dihydroxyvitamin D3 in renal failure: a controlled trial

[PDF]

557

 

 

S Madsen, K Olgaard, J Ladefoged

 

 

     

1,25 dihydroxycholecalciferol treatment of uraemic rats after high magnesium feeding

[PDF]

563

 

 

U Binswanger, H Schiffl, M Huggler, C Becker

 

 

     

Deterioration of renal function in non-dialytic uraemics caused by 1α(OH)D3 which was not attributable to hypercalcaemia

[PDF]

569

 

 

N Yoshiyama, T Akiba, N Matsui, H iwamoto, M Ogura, S Nakagawa, J Takeuchi

 

 

     
PART XVII – GUEST LECTURE    
     

Metabolic alterations caused by uraemia

[PDF]

577

 

 

R Dzurik

 

 

     
PART XVIII – NEPHROLOGY 1    
     

Metabolic effects of long-term diversion of renal venous blood into the portal system

[PDF]

589

 

 

F Kokot, T Paliwoda, Z Bulanowski, A Bochenek, Z herman, M Wieczorek, J Dobosz

 

 

     

Haemolytic uraemic syndrome: report of a case and new pathogenetic concepts

[PDF]

598

 

 

G Ramuzzi, R Misiani, D Marchesi, M Livio, G de Gaetano, M B Donati, G Mecca

 

 

     

The effect of parathyroid hormone (PTH) and 1,25 dihydroxy vitamin D3 (1,25(OH)2 D3) on RNA and HEME synthesis by erythroid precursors

[PDF]

603

 

 

J Levi, D Zevin, H Bessler, M Djaldetti

 

 

       
       
PART XIX – NEPHROLOGY 2    
       

Are results of immunosuppressive therapy influenced by immunogenetic markers?

[PDF]

608

 

 

M Sasinka, S Nyulassy, R Dzurik, M Buc, I Slugen, M Pavlovic, J Stefanovic, R Menkyna

 

 

       

"In situ" immune complex nephritis and basic proteins

[PDF]

613

 

 

A Vogt, H U Schmidt, H Takamiya, S Batsford

 

 

       

Platelet-aggregating immune complexes in idiopathic glomerulophritis and SLE

[PDF]

621

 

 

N Kasai, A Parbtani, J S Cameron, V Yewdall, P Shepherd, P Verroust

 

 

       

Circulating DNA-anti-DNA complexes in lupus nephritis and idiophatic nephritis

[PDF]

629

 

 

D Gwyn, Williams, D Adu

 

 

       

BK papovavirus immune complexes in glomerulonephritis

[PDF]

637

 

 

U Donini, L Rossi, F Palanchetti, P Zucchelli, F Pli, G Altavilla, A Corallini, G Barbanti-Brodano

 

 

       

Human glomerulonephritis and persistent non-polio enterovirus infection

[PDF]

644

 

 

F C Berthoux, O G gaudin, O Sterczinski, R Granouillet, C Genin

 

 

       

Effect of plasmapheresis (PP), corticosteroids and cyclophosphamide in essential mixed polyclonal cryoglobulinaemia associated with glomerulonephritis

[PDF]

650

 

 

D A Houwert, R J Henè, A Struyvenberg, L Kater

 

 

       
       
PART XX – POSTERS ON NEPHROLOGY    
     

Increase of IgG-bearing peripheral blood lymphocytes and hypo IgG-globulinaemia in minimal change glomerulonephritis and focal glomerulosclerosis

[PDF]

655

 

 

P Dall'Aglio. P L Meroni, L Allegri, E Ciccone, C Chizzolini, G De Bartolo, C Messina, G Savazzi

 

 

       

A possible common pathogenesis of the mesangial IgA glomerulonephritis in patients with Berger's disease and Schonlein-Henoch syndrome

[PDF]

660

 

 

J Egido, J Sancho, F Mampaso, M Lopez Trascasa, M Sanchez Crespo, R Blasco, L Hernando

 

 

       

A new test for IgA containing immune complexes or aggregated IgA: its application to Berger and Schonlein-Henoch nephritis

[PDF]

667

 

 

R. Coppo, M. De Marchi, A. Aprato, D. Roccatello, M. Messina, G. Segoloni, G. Camussi, S. Alloatti, F. Gioacchino, A. O. Carbonara, A. Vercellone, G. Piccoli

 

 

       

HLA antigens in children with idiopathic nephrotic symdrome

[PDF]

673

 

 

V. Lenhard, J Dippell, D. E. Muller-Wiefel, D. Schroeder, S. Seidl, K. Scharer

 

 

       

Mycotic urinary tract infection in pyelonephritic patients

[PDF]

678

 

 

G. Kraatz, H. Bernhardt, W. Dutz, F. Neubauer

 

 

       

Prevention of ischaemic acidodis: a new approach to acute renal failure

[PDF]

681

 

 

L. Chan, K R Thulborn, J C Waterton, J G G Ledingham, B D Ross, G K Radda

 

 

       

Allievation of ischaemic acute renal failure by beta blockers: specific tubular receptor blockade or membrane stabilising effect?

[PDF]

686

 

 

I. Iaina, I. Serban, S. Gavendo, S. Kapuler, H. E. Eliahou

 

 

       

Steroid pulses and plasmapheresis in the treatment of acute renal failure in multiple myeloma

[PDF]

690

 

 

F. Locatelli, C. Pozzi, L. Pedrini, P. Marai, S. Di Filippo, R. Ponti, R. Costanzo

 

 

       

Ammonia and amino acid metabolism by the portal-vein-draibed viscera in chronic renal insufficienty

[PDF]

695

 

 

A. Tizianello, G. De Ferrari, G. Garibotto, G. M. Chiggeri, C. Robaudo, G. Motta, M. Nauhn

 

 

       

Alpha-ketoglutarate versus ketoacids as dietetic substitutes in chronic renal insufficiency

[PDF]

700

 

 

E. Meisinger, I Schubert, E. Zimmermann, M. Strauch

 

 

       

Haemodynamic and metabolic responses to physical training in chronic renal failure

[PDF]

702

 

 

£. Roseler, R. Aurisch, K, Precht, D. Strangfeld, F. Priem, H. Siewert, K Lindenau

 

 

       

Echocardiographic detection of cardiac involvement in uraemia

[PDF]

707

 

 

B R Metha, M A Ireland, M F Shiu, B H B Robinson

 

 

       

A neurophysiological bedside technique for monitoring uraemic brain dysfunction

[PDF]

714

 

 

O knoll, U Harbort, K Schulte, F. Zimpel, H Losse

 

 

       

Long term effect of captopril in hypertension with chronic renal failure

[PDF]

719

 

 

J-P Gassia, D. Durand, H. Ton That, F. Deghroc, J-M. Suc

 

 

       

Damage to testicular function in chronic renal failure of children

[PDF]

725

 

 

K Sharer, M Broyer, P Vecsei, M Roger, E Arnold-Schwender, J Usberti

 

 

       

Oxalosis in chronic renal failure

[PDF]

730

 

 

C T op de Hock, Ph P N M Diderich, S Gratana, E J M Weijs- v Hofwegen

 

 

       

Effect of 1 αhydroxylated vitam D on steroid induced calcium malabsorption [PDF]

736

 

 

H Graf, H K Stummvoll, J Kovarik, H Bergmann, A Wolf

 

 

       
PART XXI    
       

Selection of papers for the 17th EDTA congress

[PDF]

743

 

 

C. Mion

 

 

       
     

Membership of the European Dialysis and Transplant Association

[PDF]

747

 

 

 

 

 

Subject Index

[PDF]

749

 

     
Author Index
759
 

 

In order to open the above PDF files you need Acrobat Reader.

If you do not have it, you can download it here